Skip to content

Kenvue unveils new survey data on menopause and announces sponsorship of Scholarship Program for Menopause Education

Kenvue set to attend the Annual Meeting of The Menopause Society, as the company sponsors a scholarship program in menopause education and shares new data in the women’s hormonal health space

menopause survey

September 27, 2023 – Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will unveil new data from an attitudes and usage study during a poster presentation, “Clearing the fog: Learning about menopause through the experiences of 4,500 women aged 40-65,” during the Annual Meeting of The Menopause Society in Philadelphia, Pennsylvania September 27 – 30.

At the Annual Meeting, Kenvue will also announce its sponsorship and funding of The Menopause Society scholarship program, contributing to clinicians earning the credential or recredentialing as a Menopause Society Certified Practitioner (MSCP). The goal of Kenvue (the parent company of iconic brands such as Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®) is to help expand the number of clinicians who are trained to help their patients navigate menopause by supporting the MSCP credential.

Dr. Mary Jane Minkin, part of Kenvue’s Women’s Health Advisory Board and a clinical professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the Yale University School of Medicine, called the Menopause Society’s scholarship program “crucial,” as only 31% of OB/GYN residencies in the United States offer menopause training as part of their curriculum. As a result, some individuals may find it challenging to receive menopause support and care in their local healthcare professionals’ office.

“The Menopause Society’s Scholarship Program supporting the credentialing or re-credentialing of clinicians as Menopause Society Certified Practitioners (MSCPs) will have a dramatic impact in helping to treat, diagnose, and empower women at different stages of their hormonal health journey and Kenvue is proud to be a sponsor,” said Adam Ricciardone1, Global Vice President, Kenvue Self Care.

The attitudes and usage study will be presented by Benjamin Klein2, Associate Director of Consumer Business Intelligence for Kenvue Self Care. The U.S.-based study included a diverse population of 4,578 women aged 40 to 65 years spanning pre-, peri- and post-menopausal stages who completed an online quantitative survey about their symptoms related to the menopause transition over a three-week period.

According to the survey, over a third of peri/menopausal women (39% and 31% respectively) are experiencing symptoms of menopause that are affecting their quality of life, but many women do not seek the help they need with this transitional life stage because they do not immediately recognize that symptoms such as hot flashes, fatigue, night sweats, brain fog, memory issues and joint pain are related to menopause.

“These findings clarify an opportunity to improve women’s health through the extraordinary power of everyday care,” Klein said. “By educating patients, providers and the community, we can close the menopause awareness gap to help ensure that women receive more support and feel empowered across each phase of the journey.”

Klein is presenting his data on Thursday, September 28 at 6:15 pm in Franklin Hall of the Marriott Downtown Philadelphia. For more information or to schedule an interview on this new data, or regarding The Menopause Society Scholarship Program and Kenvue’s efforts in women’s health, please use the media contact information below.

Media Contact:
[email protected]

1. Adam Ricciardone is an employee of Johnson & Johnson Consumer Inc., a subsidiary of Kenvue.
2. Benjamin Klein is an employee of Johnson & Johnson Consumer Inc., a subsidiary of Kenvue